Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 2, 2006, Pages 295-301

  Cardenas, V M ^a,f   Graham, D Y ^b   El Zimaity, H M T ^b,c   Opekun, A R ^b   Campos, A ^d   Chavez, A ^e   Guerrero, L ^d  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Regional General Hospital   (Mexico)

^e Gastroenterology Specialists of El Paso   (United States)

^f UT School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; RABEPRAZOLE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BELCHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; ERADICATION THERAPY; FECES; FEMALE; GASTROINTESTINAL INFECTION; GEOGRAPHIC DISTRIBUTION; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; LASSITUDE; MAJOR CLINICAL STUDY; MALE; METALLIC TASTE; MEXICO; MYALGIA; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; THRUSH; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UNITED STATES; UREA BREATH TEST; VAGINITIS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT COMPLIANCE; PILOT PROJECTS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33644879978     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02755.x     Document Type: Article

References (24)

1. Nakayama Y Graham DY Helicobacter pylori infection: diagnosis and treatment Expert Rev Anti Infect Ther 2004 2 599 610
2. Malfertheiner P Megraud F O'Morain C et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report Aliment Pharmacol Ther 2002 16 167 80
3. Fischbach LA Goodman KJ Feldman M Aragaki C Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis Int J Epidemiol 2002 31 128 39
4. Ford A Moayyedi P How can the current strategies for Helicobacter pylori eradication therapy be improved Can J Gastroenterol 2003 17 Suppl. B 36B 40B
5. Moayyedi P Feltbower R Crocombe W et al. The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group Aliment Pharmacol Ther 2000 14 719 28
6. Della Monica P Lavagna A Masoero G Lombardo L Crocella L Pera A Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy Aliment Pharmacol Ther 2002 16 1269 75
7. Gene E Calvet X Azagra R Gisbert JP Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis Aliment Pharmacol Ther 2003 17 1137 43
8. Fischbach LA van Zanten S Dickason J Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies Aliment Pharmacol Ther 2004 20 1071 82
9. Dore MP Leandro G Realdi G Sepulveda AR Graham DY Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach Dig Dis Sci 2000 45 68 76
10. Gisbert JP Khorrami S Calvet X Gabriel R Carballo F Pajares JM Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists - their efficacy with antibiotics in Helicobacter pylori eradication Aliment Pharmacol Ther 2003 18 757 66
11. Laheij RJ Rossum LG Jansen JB Straatman H Verbeek AL Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis Aliment Pharmacol Ther 1999 13 857 64
12. Broutet N Tchamgoue S Pereira E Lamouliatte H Salamon R Megraud F Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients Aliment Pharmacol Ther 2003 17 99 109
13. Vakil N Lanza F Schwartz H Barth J Seven-day therapy for Helicobacter pylori in the United States Aliment Pharmacol Ther 2004 20 99 107
14. Tovar-Guzmán V Hernández-Girón C Barquera S Rodríguez-Salgado N Lizbeth López-Carrillo A Epidemiologic panorama of stomach cancer mortality in Mexico Arch Med Res 2001 32 312 7
15. López-Carrillo L Vega-Ramos B Costa Dias R Rascón-Pacheco R Histological types of gastric cancer in Mexico Int J Epidemiol 1997 26 1166
16. El-Zimaity HM Graham DY Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System Hum Pathol 1999 30 72 7
17. El-Zimaity HM Al-Assi MT Genta RM Graham DY Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test Am J Gastroenterol 1995 90 1962 4
18. El-Zimaity HM Accurate diagnosis of Helicobacter pylori with biopsy Gastroenterol Clin North Am 2000 29 863 9
19. El-Zimaity HM Graham DY Al-Assi MT et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis Hum Pathol 1996 27 35 41
20. Opekun AR Abdalla N Sutton FM et al. Urea breath testing and analysis in the primary care office J Fam Pract 2002 51 1030 2
21. Graham DY Klein PD Accurate diagnosis of Helicobacter pylori. 13C-urea breath test Gastroenterol Clin North Am 2000 29 885 93
22. Dean AG Dean JA Burton AH Dicker RC Epi Info: a general-purpose microcomputer program for public health information systems Am J Prev Med 1991 7 178 82
23. Vergara M Vallve M Gisbert JP Calvet X Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication Aliment Pharmacol Ther 2003 18 647 54
24. van Doorn LJ Schneeberger PM Nouhan N Plaisier AP Quint WG de Boer WA Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment Gut 2000 46 321 26